Hypercalcemia in children with rhabdomyosarcoma

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 4, 1998, Pages 327-329

  Kawasaki, Hirohide ^a,b   Takayama, Jun ^b   Nagasaki, Koichi ^c   Yamaguchi, Ken ^c   Ohira, Mutsuro ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NONE

Author keywords

Hypercalcemia; Parathyhyroid hormone related protein (PTHrP); Rhabdomyosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CALCITONIN; CALCIUM; FUROSEMIDE; MITHRAMYCIN; PARATHYROID HORMONE RELATED PROTEIN;

ADOLESCENT; ARTICLE; BONE ATROPHY; BONE METASTASIS; CHILD; FEMALE; HUMAN; HYPERCALCEMIA; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RHABDOMYOSARCOMA; SYMPTOMATOLOGY;

ADOLESCENT; BONE MARROW; BONE RESORPTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERCALCEMIA; INCIDENCE; INFANT; MALE; NEOPLASM PROTEINS; PARATHYROID HORMONE-RELATED PROTEIN; PROTEINS; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA;

EID: 0031728962     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199807000-00009     Document Type: Article

References (16)

1. Vassilopoulou-Sellin R, Newman BM, Taylor SH, et al. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer 1993;71:1309-12.
2. Leblanc A, Caillaud JM, Hartmann O, et al. Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. Cancer 1984;54: 2132-6.
3. McKay C, Furman WL. Hypercalcemia complicating childhood malignancies. Cancer 1993;72:256-60.
4. Nagasaki k, Otsubo k, Kajimura N, et al. Circulating parathyroid hormone-related protein (109-141) in malignancy-associated hypercalcemia. Jpn J Clin Oncol 1996;26:6-11.
5. Bilezikian JP. Management of acute hypercalcemia. N Engl J Med 1992;326:1196-203.
6. Fujino T, Watanabe T, Yamaguchi K, et al. The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein. Cancer 1992;70:2845-50.
7. Kutluk MT, Hazar V, Akyuz C, et al. Childhood cancer and hypercalcemia: report of a case treated with pamidronate. J Pediatr 1997;130:828-31.
8. Young G, Shende A. Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Pediatr Oncol 1998;30:1177-21.
9. Hutchinson RJ, Shapiro SA, Raney RB. Elevated parathyroid hormone levels in association with rhabdomyosarcoma. J Pediatr 1978;92:780-1
10. Almanaseer IY, Trujillo YP, Taxy JB, et al. Systemic rhabdomyosarcoma with diffuse bone marrow involvement. J Clin Pathol 1984;82:349-53.
11. Elomaa I, Lehto VP, Selander RK. Hypercalcemia and elevated serum parathyroid hormone level in association with rhabdomyosarcoma. Arch Pathol Lab Med 1984;108:701-3.
12. de la Serna FJ, Martinez MA, Valdes MD, et al. Rhabdomyosarcoma presenting with diffuse bone marrow involvement, hypercalcemia and renal failure. Med Pediatr Oncol 1988;16:123-7.
13. Grill V, Ho P, Body JJ, et al. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endcrinol Metab 1991;73:1309-15.
14. Bundred NJ, Ratcliffe WA, Walker RA, et al. Parathyroid hormone related protein and hypercalcemia in breast cancer. Br Med J 1991;303:1506-9.
15. Powell GJ, Southby J, Danks JA, et al. Localization of parathyroid hormone-related protein in breast cancer metastasis: increased incidence in bone compared with other sites. Cancer Res 1991;51:3059-61.
16. Bundred NJ, Walker RA, Ratcliffe WA, et al. Parathyroiid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 1992;28:690-2.